Test Price
2,800 AED✅ Home Collection Available
TTC8 Gene Bardet-Biedl Syndrome Type 8 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy: Diagnostic sensitivity up to 99.9% via ISO-certified processing.
- Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic consultation for result interpretation.
- Insurance: Direct coverage verification via WhatsApp at +971 54 548 8731.
- Turnaround Time: 3–4 weeks from sample receipt.
- Price: 2800 AED – includes full genetic analysis and counseling support.
Test Overview & Methodology
This advanced next‑generation sequencing (NGS) test detects pathogenic variants in the TTC8 gene, confirming Bardet‑Biedl Syndrome type 8. The analysis requires only a small blood sample, extracted DNA, or a single drop on an FTA card, and is processed under ISO‑certified protocols with a turnaround time of 3–4 weeks.
| Test Parameter | Our Test (NGS) | Closest Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – Full Gene Analysis | Sanger Sequencing (limited to known hotspots) |
| Turnaround Time | 3–4 weeks | 4–6 weeks or longer |
| Sample Options | Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot) | Whole Blood Only (venipuncture) |
| Diagnostic Yield | High coverage, detecting rare pathogenic variants | Lower sensitivity for novel mutations |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Geneticist, I emphasize that a positive TTC8 mutation confirms Bardet‑Biedl syndrome and demands a comprehensive multidisciplinary evaluation, including renal, endocrine, and ophthalmologic assessments. Results must always be interpreted alongside clinical symptoms and family history; a negative test does not exclude other ciliopathies or genetic disorders. Please remember that no genetic result should prompt sudden discontinuation of prescribed therapies.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication, including treatments for associated conditions, without explicit consultation with your managing physician. Genetic test results are meant to guide long-term management, not to alter acute therapy.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection or immunosuppression – consult your physician before blood draw.
- Pregnant women should undergo pre‑test genetic counselling and discuss any additional risks.
- Minors require legal guardian consent under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: If the patient develops severe oliguria, anuria, acute metabolic decompensation, or life‑threatening arrhythmia, seek immediate emergency care – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the TTC8 gene Bardet‑Biedl syndrome type 8 NGS test?
This advanced NGS analyzes the TTC8 gene for pathogenic mutations causing Bardet‑Biedl syndrome type 8 with high precision. It is the gold‑standard molecular test for confirming this rare ciliopathy.
2. How is the sample collected and what are the requirements?
Samples can be collected via our VIP home phlebotomy service (whole blood) or by providing extracted DNA or a simple FTA card finger‑prick. The specimen is transported under cold‑chain protocols to ensure DNA integrity.
3. How long do results take and what are the next steps?
Results are delivered within 3–4 weeks. A mandatory post‑test genetic counseling session is scheduled to interpret the report, discuss implications, and coordinate with your multidisciplinary care team.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient confidentiality and data security are paramount.
Clinical Safety & Consent: Sample collection and reporting adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Informed consent is obtained before any genetic analysis, and all procedures minimize risk.
Licensing: The test is performed at DNA Labs UAE under DHA Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | TTC8 Gene Bardet-Biedl Syndrome Type 8 Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Analysis |
| ICD-10-CM Code | Q87.89 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License: 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians